BlackRock’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.5M | Buy |
|
|||||
|
2025
Q1 | $41.9M | Buy |
|
|||||
|
2024
Q4 | $43.6M | Buy |
|
|||||
|
2024
Q3 | $40.3M | Buy |
|
|||||
|
2024
Q2 | $46M | Sell |
|
|||||
|
2024
Q1 | $33.5M | Sell |
|
|||||
|
2023
Q4 | $35.2M | Buy |
|
|||||
|
2023
Q3 | $29.2M | Sell |
|
|||||
|
2023
Q2 | $71.2M | Buy |
|
|||||
|
2023
Q1 | $68.6M | Sell |
|
|||||
|
2022
Q4 | $76.3M | Buy |
|
|||||
|
2022
Q3 | $96.8M | Buy |
|
|||||
|
2022
Q2 | $106M | Sell |
|
|||||
|
2022
Q1 | $110M | Sell |
|
|||||
|
2021
Q4 | $154M | Buy |
|
|||||
|
2021
Q3 | $166M | Sell |
|
|||||
|
2021
Q2 | $212M | Sell |
|
|||||
|
2021
Q1 | $151M | Buy |
|
|||||
|
2020
Q4 | $129M | Buy |
|
|||||
|
2020
Q3 | $89.6M | Sell |
|
|||||
|
2020
Q2 | $108M | Buy |
|
|||||
|
2020
Q1 | $93.8M | Sell |
|
|||||
|
2019
Q4 | $154M | Buy |
|
|||||
|
2019
Q3 | $121M | Buy |
|
|||||
|
2019
Q2 | $127M | Buy |
|
|||||
|
2019
Q1 | $157M | Sell |
|
|||||
|
2018
Q4 | $229M | Sell |
|
|||||
|
2018
Q3 | $203M | Buy |
|
|||||
|
2018
Q2 | $94.5M | Buy |
|
|||||
|
2018
Q1 | $71.9M | Sell |
|
|||||
|
2017
Q4 | $69.4M | Buy |
|
|||||
|
2017
Q3 | $79.9M | Sell |
|
|||||
|
2017
Q2 | $72.8M | Buy |
|
|||||
|
2017
Q1 | $53.9M | Buy |
|
|||||
|
2016
Q4 | $150K | Sell |
|
|||||
|
2016
Q3 | $332K | Sell |
|
|||||
|
2016
Q2 | $249K | Buy |
|
|||||
|
2016
Q1 | $42K | Buy |
|
|||||
|
2015
Q4 | $12K | Sell |
|
|||||
|
2015
Q3 | $23K | Buy |
|
|||||
|
2015
Q2 | $9K | Sell |
|
|||||
|
2015
Q1 | $9K | Hold |
|
|||||
|
2014
Q4 | $13K | Buy |
|
|||||
|
2014
Q3 | $8K | Hold |
|
|||||
|
2014
Q2 | $13K | Sell |
|
|||||
|
2014
Q1 | $15K | Hold |
|
|||||
|
2013
Q4 | $11K | Hold |
|
|||||
|
2013
Q3 | $10K | Hold |
|
|||||
|
2013
Q2 | $7K | Buy |
|